Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
46.73
+0.73 (1.59%)
At close: Jul 31, 2026, 4:00 PM EDT
46.70
-0.03 (-0.06%)
After-hours: Jul 31, 2026, 7:56 PM EDT
Boston Scientific Stock Forecast
Stock Price Forecast
According to 31 analysts polled by S&P Global, Boston Scientific stock has a consensus rating of "Buy" and an average price target of $62.69. The average 1-year stock price forecast is 34.15% higher than the current stock price, while the lowest is $44 (-5.84%) and the highest is $94 (+101.16%).
Price Target: $62.69 (+34.15%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Boston Scientific stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 25 | 24 | 22 | 21 | 20 | 19 |
| Buy | 9 | 10 | 9 | 7 | 7 | 8 |
| Hold | 0 | 0 | 2 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 34 | 34 | 33 | 32 | 31 | 31 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Argus Research | Argus Research | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Jul 31, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Reiterates $80 → $56 | Buy | Reiterates | $80 → $56 | +19.84% | Jul 30, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $65 → $55 | Buy | Maintains | $65 → $55 | +17.70% | Jul 30, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $85 | Buy | Maintains | $85 | +81.90% | Jul 30, 2026 |
| Deutsche Bank | Deutsche Bank | Buy Maintains $75 → $60 | Buy | Maintains | $75 → $60 | +28.40% | Jul 30, 2026 |
Financial Forecast
Revenue This Year
21.56B
from 20.07B
Increased by 7.42%
Revenue Next Year
23.29B
from 21.56B
Increased by 8.02%
EPS This Year
3.36
from 3.06
Increased by 9.81%
EPS Next Year
3.71
from 3.36
Increased by 10.48%
EPS and Forward PE are based on non-GAAP adjusted numbers.